LJHT
Laurie J. Hall Trustee Portfolio holdings
AUM
$302M
This Quarter Return
+0.34%
1 Year Return
+17.68%
3 Year Return
+82.52%
5 Year Return
+131.39%
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(-8%)
Cap. Flow
-$21.4M
Cap. Flow
% of AUM
-7.65%
Top 10 Holdings %
Top 10 Hldgs %
36.7%
Holding
251
New
–
Increased
11
Reduced
74
Closed
141
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
$865K |
| 2 |
RELX
RELX
|
$816K |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
$804K |
| 4 |
Crown Holdings
CCK
|
$765K |
| 5 |
Becton Dickinson
BDX
|
$194K |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$1.95M |
| 2 |
Canadian National Railway
CNI
|
$1.1M |
| 3 |
iShares Russell 3000 ETF
IWV
|
$1.08M |
| 4 |
Microsoft
MSFT
|
$1.06M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$785K |
Sector Composition
| 1 | Technology | 29.37% |
| 2 | Healthcare | 22.57% |
| 3 | Industrials | 15.58% |
| 4 | Consumer Staples | 9.35% |
| 5 | Financials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AptarGroup
ATR
$9.18B
| $3.93M | 1.4% | 26,475 +465 | +2% | +$69K |
|
27
Fiserv
FI
$75.1B
| $3.93M | 1.4% | 17,775 -510 | -3% | -$113K |
|
28
Xylem
XYL
$34.5B
| $3.84M | 1.37% | 32,136 -999 | -3% | -$119K |
|
29
New York Times
NYT
$9.74B
| $3.5M | 1.25% | 70,640 -1,490 | -2% | -$73.9K |
|
30
UL Solutions
ULS
$12.7B
| $3.16M | 1.13% | 56,055 +2,005 | +4% | +$113K |
|
31
AbbVie
ABBV
$372B
| $3.12M | 1.11% | 14,895 -615 | -4% | -$129K |
|
|
32
Crown Holdings
CCK
$11.6B
| $3.03M | 1.08% | 33,990 +8,565 | +34% | +$765K |
|
33
Unilever
UL
$155B
| $3.03M | 1.08% | 50,815 -1,180 | -2% | -$70.3K |
|
34
Novartis
NVS
$245B
| $2.91M | 1.04% | 26,142 -1,073 | -4% | -$120K |
|
|
35
Becton Dickinson
BDX
$55.3B
| $2.87M | 1.02% | 12,510 +848 | +7% | +$194K |
|
36
3M
MMM
$82.8B
| $2.81M | 1% | 19,131 -1,062 | -5% | -$156K |
|
37
Amazon
AMZN
$2.44T
| $2.72M | 0.97% | 14,280 -450 | -3% | -$85.6K |
|
38
Vertex Pharmaceuticals
VRTX
$100B
| $2.68M | 0.96% | 5,528 +385 | +7% | +$187K |
|
39
Air Products & Chemicals
APD
$65.5B
| $2.31M | 0.82% | 7,835 -1,190 | -13% | -$351K |
|
40
Advanced Micro Devices
AMD
$264B
| $2.28M | 0.81% | 22,180 -1,704 | -7% | -$175K |
|
41
Sysco
SYY
$38.5B
| $2.16M | 0.77% | 28,783 -625 | -2% | -$46.9K |
|
42
Morgan Stanley
MS
$240B
| $2.1M | 0.75% | 18,000 | – | – |
|
43
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.03M | 0.72% | 3,803 | – | – |
|
44
Merck
MRK
$210B
| $1.98M | 0.71% | 22,104 -1,350 | -6% | -$121K |
|
45
Veralto
VLTO
$26.4B
| $1.96M | 0.7% | 20,082 +1,133 | +6% | +$110K |
|
46
Amgen
AMGN
$155B
| $1.85M | 0.66% | 5,945 -175 | -3% | -$54.5K |
|
47
Parker-Hannifin
PH
$96.2B
| $1.84M | 0.66% | 3,033 | – | – |
|
48
iShares MSCI EAFE ETF
EFA
$66B
| $1.79M | 0.64% | 21,879 -1,546 | -7% | -$126K |
|
|
49
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.63M | 0.58% | 2,907 -1,403 | -33% | -$785K |
|
50
AT&T
T
$209B
| $1.62M | 0.58% | 57,362 -3,663 | -6% | -$104K |
|